TCR2 THERAPEUTICS Trademark

Trademark Overview


On Thursday, October 28, 2021, a trademark application was filed for TCR2 THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the TCR2 THERAPEUTICS trademark a serial number of 97097081. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, December 11, 2023. This trademark is owned by TCR2 Therapeutics Inc.. The TCR2 THERAPEUTICS trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical preparations, namely, therapeutic cells, therapeutic proteins and therapeutic nucleic acids for human use for the treatment and prevention of cancer, inflammation and inflammatory diseases; pharmaceutical preparations for human use, namely, biotherapeutics, medicines, and therapeutics, namely, pharmaceutical polypeptides, pharmaceutical antibodies, pharmaceutical nucleic acids, polypeptide-based therapeutics, cell-based therapeutics, RNA-based therapeutics, and DNA-based therapeutics for the treatment and prevention of cancer, inflammation and inflammatory diseases

Scientific research in the fields of pharmaceuticals, pharmaceutical research and development, laboratory testing, biotechnology, medicine, biologics, biotherapeutics, biosimilars, cancer treatment, oncology, and therapeutics, namely, polypeptide-based therapeutics, RNA-based therapeutics, and DNA-based therapeutics; providing information on the subject of scientific research in the fields of pharmaceuticals, pharmaceutical research and development, laboratory testing, biotechnology, medicine, biologics, biotherapeutics, biosimilars, cancer treatment, oncology, and therapeutics, namely, polypeptide-based therapeutics, RNA-based therapeutics, and DNA-based therapeutics
tcr2 therapeutics

General Information


Serial Number97097081
Word MarkTCR2 THERAPEUTICS
Filing DateThursday, October 28, 2021
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, December 11, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, September 13, 2022

Trademark Statements


Description of MarkThe mark consists of the stylized letters TCR and stylized number 2 above the stylized word THERAPEUTICS.
Goods and ServicesPharmaceutical preparations, namely, therapeutic cells, therapeutic proteins and therapeutic nucleic acids for human use for the treatment and prevention of cancer, inflammation and inflammatory diseases; pharmaceutical preparations for human use, namely, biotherapeutics, medicines, and therapeutics, namely, pharmaceutical polypeptides, pharmaceutical antibodies, pharmaceutical nucleic acids, polypeptide-based therapeutics, cell-based therapeutics, RNA-based therapeutics, and DNA-based therapeutics for the treatment and prevention of cancer, inflammation and inflammatory diseases
Pseudo MarkTCR TWO THERAPEUTICS
Disclaimer with Predetermined Text"TCR" and "THERAPEUTICS"
Goods and ServicesScientific research in the fields of pharmaceuticals, pharmaceutical research and development, laboratory testing, biotechnology, medicine, biologics, biotherapeutics, biosimilars, cancer treatment, oncology, and therapeutics, namely, polypeptide-based therapeutics, RNA-based therapeutics, and DNA-based therapeutics; providing information on the subject of scientific research in the fields of pharmaceuticals, pharmaceutical research and development, laboratory testing, biotechnology, medicine, biologics, biotherapeutics, biosimilars, cancer treatment, oncology, and therapeutics, namely, polypeptide-based therapeutics, RNA-based therapeutics, and DNA-based therapeutics

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, August 10, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, November 9, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameTCR2 Therapeutics Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Party NameTCR2 Therapeutics Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Trademark Events


Event DateEvent Description
Monday, December 11, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, December 11, 2023ABANDONMENT - NO USE STATEMENT FILED
Thursday, April 6, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 4, 2023SOU EXTENSION 1 GRANTED
Tuesday, April 4, 2023SOU EXTENSION 1 FILED
Tuesday, April 4, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, November 8, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 13, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 13, 2022PUBLISHED FOR OPPOSITION
Wednesday, August 24, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, August 10, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 10, 2022EXAMINER'S AMENDMENT ENTERED
Wednesday, August 10, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, August 10, 2022EXAMINERS AMENDMENT E-MAILED
Wednesday, August 10, 2022EXAMINERS AMENDMENT -WRITTEN
Monday, August 8, 2022ASSIGNED TO EXAMINER
Tuesday, November 9, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, November 1, 2021NEW APPLICATION ENTERED